Showing results (381-390 of 521) with videos related to

Sort By:
Pageof 53
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1994
In vitro study of the effect of urotensin II on corticosteroid secretion in the frog Rana ridibundaM Feuilloley, O Lesouhaitier, C Delarue, et al.
European Journal of Biochemistry|January 29, 2000
Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiensJ Goraya, Y Wang, Z Li, et al.
Peptides|June 11, 1998
Purification and cardiovascular activity of [Met1, Met5]-bradykinin from the plasma of a sturgeon (Acipenseriformes)Z Li, M P Smith, D W Duff, et al.
Regulatory Peptides|April 1, 1999
Molecular evolution of peptide tyrosine--tyrosine: primary structure of PYY from the lampreys Geotria australis and Lampetra fluviatilis, bichir, python and desert tortoiseY Wang, P F Nielsen, J H Youson, et al.
Endocrinology|February 4, 1998
Ranakinin, a naturally occurring tachykinin, stimulates phospholipase C activity in the frog adrenal glandM K Kodjo, L Desrues, L Lavagno, et al.
American Journal of Obstetrics and Gynecology|January 1, 1990
Local cerebral blood flow is increased in rapid-eye-movement sleep in fetal sheepR M Abrams, J C Post, D J Burchfield, et al.
Frontiers in Pediatrics|January 16, 2023
Adjusting ventilator settings to avoid air trapping in extremely premature infants reduces the need for tracheostomy and length of stayIbrahim Sammour, Steven M Conlon, Sarah E Bauer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 17, 2014
Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPDGerrit John-Schuster, Katrin Hager, Thomas M Conlon, et al.
Endocrinology|November 1, 1993
Immunohistochemical distribution, biochemical characterization, and biological action of tachykinins in the frog adrenal glandF Leboulenger, L Vaglini, J M Conlon, et al.
Bone Marrow Transplantation|July 31, 2001
HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell supportM Bewick, M Conlon, S Gerard, et al.
Pageof 53